Oxidant stress - The general mechanism of disturbances in nervous system diseases

Zhurnal Nevropatolgii i Psikhiatrii im. S S Korsakova

Volumn 96, Issue 2, 1996, Pages 111-114

  Zavalishin, I A ^a   Zakharova, M N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; OXIDIZING AGENT;

HUMAN; METABOLISM; NERVOUS SYSTEM; NEUROLOGIC DISEASE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PHYSIOLOGY; REVIEW;

FREE RADICALS; HUMANS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; OXIDANTS; OXIDATIVE STRESS; OXYGEN CONSUMPTION;

EID: 3042954369     PISSN: 00444588     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Gerschman R. Biological effects of oxygen in Oxygenin the Animal organism. In: Dickens F., Neil E., eds. Mamilan. New York 1964; 475-490.
2. Gibbert D. L. Significance of oxyden onearth in Oxyden and Living processes. Gilbert D., eds. springer-Verlag. New York 1981; 73-105.
3. Fridovich I. The biology of oxygen radicals. Science 1978; 201; 875-903.
4. Kane D. L., Sarafian A., Anton R. et al. Bcl-2 inhibition of neural death: Decrease generation of reactive oxyden species. Science 1993; 262: 1274-1277-
5. Halliwell B. Tree radicals, oxygen toxicity and aging. In: Age Pigments, ed. Sohal R. S., Elsevier/Nocta. Holland: Amsterdam 1981; 1-50.
6. Shapira A. H., Cooper J. M. Mitochondrial function in neurodegeneraton and ageing. Mutation Reseach 1992; 275: 133 -143.
7. Hattori N. B., Tanaca M., Ozawa T., Mizuno Y. Immunohistochemical studies on complexes I, II, III and IV of mitochondria in Parkinsons disease. Ann. Neurology 1991; 30: 563-571.
8. Parker W. D., Boyson S. J., Luda A. S. Evidence for a defect in NADH ubiguihone oxidoreductase (complex I) in Huntington's disease. Neurology 1990; 40: 1231-1234.
9. Parker W. D., Filley M., Parks J. K. Cytochrome oxidase defiency in Alzheimer's disease. Neurology 1990; 40: 1302-1303.
10. Sims N. R., Finegan J. M., Blass J. P. et al. Mitochondrial function in brain tissue in primaty degenerative dementia. Drain Res 1987; 436: 30-38.
11. Oliver C. N., Starke Reed P. E., Stadtman E. R. et al. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ishemia/reperfusion induced injury to gerbil brain. Proc Natl Acad Sci USA 1990; 87: 5144-5147.
12. Mattson M. P., Rudev R. E. Altered Calcium signalling and Neuonal Injury. Ann. N. - J Acad Sci 1993; 679: 1-21.
13. Sauer D., Fagg G. E. Excitatory aminoacids, excitotoxicity and neurodegenerative disorders. In: Lassen P., Hansen J. J., ed. Exicitatory Amino Acid Receptors. New York: Ellis Horwood, 1992; 13-34.
14. Heyes M. P., Lackner A. AIDS-dementhia and excitototoxicity. J Neurochem 1991; 55: 338-341.
15. Tsai G. Reductions in acidic amino acids and N-acetylaspartylglutamate in ALS. Brain Res 1991; 556: 151-156.
16. Coyle J. T. Oxidative stress, glutamate and neurodegenerative discorders. Science 1993; 262; 689-695.
17. Langrehz J. M., Hoffman R. A., Lancaster J. R. Nitric oxide - a new endogenous immunomodulator. Transplantation 1993; 55: 1205-1212.
18. Kavanaugh W. M., Williams L. T. An alternative to SH2 Domains for Binding Tyrosine-Phosphorylated Proteins. Science 1994; 266: 1862-1865.
19. Marcinkiewingz J., Chain B. M. Differential regulation of cytokine production by nitric oxide. Immunology 1993; 80: 146-159.
20. Murphy S., Simons M., Agullo L. et al. Synthesis of nitric oxide in CNS glial cells. TINS 1993; 16; 323-328.
21. Olanow C. W. Radical hypothesis for neurodegeneration. TINS 1993; 16: 439-445.
22. Rosen D. R., Siddigue T., Patterson L. et al. Mutations in Cu/Zn superoxide dismutase gene are assotiated with familian ALS. Nature 1993; 362: 59-62.
23. Bowling A. C., Schulz J. B. Superoxide dismutase activity, oxidative damage and mitochondrial energy metabolism in familian and sporadic ALS. J Neurochem 1993; 61: 2322-2325.
24. Evans P. H. Free radicals in brain metabolism and pathology. Dr Med Bull 1993; 49: 577-587.
25. Bensimon G., Lacomblez L., Meininger V. A controlled trial of Riluzole in amyotrophic lateral sclerosis. New Eng J Med 1994; 330: 585-591.
26. Boldyrev A. A., Formazyuk V. E., Sergienko V. I. Biological significance of histidine-containing dipeptides with special reference to carnosine. Sov Sci Rev D Physicochem Biol 1994; 13: 1-60.
27. Choi D. W. Calcium: still center - stage in hypoxic - ischemic neuronal death. Trends Neurosci 1995; 18: 58-60.
28. Issels R. D., Nagele A., Eskert K. G. Promotion of cystine uptake and its utilization for glutathione biosynthesis induced by cysteamine and N-acetylcysteine. Biochem Pharm 1988; 37: 881-888.
29. Lipton S. A., Rosenberg P. A. Excitatory amini acids a final common pathway for neurologic disorders. New Eng J Med 1994; 330: 613-629.